Search

Search Results
Results 19451 - 19460 of 19768 for Able-bodied
  • Ursofalk
    Drug - 21 May 2026
    Consumer Medicine Information (CMI) about Ursofalk intended for persons living in Australia.
  • Apretude Injection
    Drug - 13 May 2026
    Consumer Medicine Information (CMI) about Apretude Injection intended for persons living in Australia.
  • Three essential biomarkers for measuring immune activation
    White Paper - 20 Apr 2026
    Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and research applications.
  • Role of Proteomics in Systems Biology and Disease Research
    Life Sciences - 6 Apr 2026
    Integrating proteomics with systems biology reveals complex cellular networks, improving disease mechanisms understanding and precision medicine applications.
  • Trimethoprim Viatris
    Drug - 19 Mar 2026
    Consumer Medicine Information (CMI) about Trimethoprim Viatris intended for persons living in Australia.
  • Alprim
    Drug - 19 Mar 2026
    Consumer Medicine Information (CMI) about Alprim intended for persons living in Australia.
  • Tresiba Penfill
    Drug - 18 Feb 2026
    Consumer Medicine Information (CMI) about Tresiba Penfill intended for persons living in Australia.
  • NovoRapid Vial
    Drug - 12 Feb 2026
    Consumer Medicine Information (CMI) about NovoRapid Vial intended for persons living in Australia.
  • Fluticasone Furoate Viatris
    Drug - 4 Feb 2026
    Consumer Medicine Information (CMI) about Fluticasone Furoate Viatris intended for persons living in Australia.
  • Ryzodeg 70/30 Penfill
    Drug - 4 Dec 2025
    Consumer Medicine Information (CMI) about Ryzodeg 70/30 Penfill intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback